[go: up one dir, main page]

NO20000284D0 - Tannic acid polymer compositions for controlled release of pharmaceutical agents, especially in the oral cavity - Google Patents

Tannic acid polymer compositions for controlled release of pharmaceutical agents, especially in the oral cavity

Info

Publication number
NO20000284D0
NO20000284D0 NO20000284A NO20000284A NO20000284D0 NO 20000284 D0 NO20000284 D0 NO 20000284D0 NO 20000284 A NO20000284 A NO 20000284A NO 20000284 A NO20000284 A NO 20000284A NO 20000284 D0 NO20000284 D0 NO 20000284D0
Authority
NO
Norway
Prior art keywords
controlled release
oral cavity
acid polymer
polymer compositions
pharmaceutical agents
Prior art date
Application number
NO20000284A
Other languages
Norwegian (no)
Other versions
NO20000284L (en
Inventor
E Itzhak Lerner
Vered Rosenberger
Moshe Flashner
Original Assignee
Perio Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perio Prod Ltd filed Critical Perio Prod Ltd
Publication of NO20000284D0 publication Critical patent/NO20000284D0/en
Publication of NO20000284L publication Critical patent/NO20000284L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000284A 1997-07-23 2000-01-20 Tannic acid polymer compositions for controlled release of pharmaceutical agents, especially in the oral cavity NO20000284L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89912197A 1997-07-23 1997-07-23
PCT/US1998/015096 WO1999004764A1 (en) 1997-07-23 1998-07-22 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity

Publications (2)

Publication Number Publication Date
NO20000284D0 true NO20000284D0 (en) 2000-01-20
NO20000284L NO20000284L (en) 2000-03-22

Family

ID=25410514

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000284A NO20000284L (en) 1997-07-23 2000-01-20 Tannic acid polymer compositions for controlled release of pharmaceutical agents, especially in the oral cavity

Country Status (10)

Country Link
EP (1) EP1003483A1 (en)
JP (1) JP2001510788A (en)
KR (1) KR20010021911A (en)
AU (1) AU8578498A (en)
BR (1) BR9811478A (en)
CA (1) CA2296654A1 (en)
HU (1) HUP0002490A2 (en)
IL (1) IL134151A0 (en)
NO (1) NO20000284L (en)
WO (1) WO1999004764A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US6881420B2 (en) 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
EP1305021A4 (en) * 2000-06-23 2009-09-23 Teva Pharma Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
ATE369184T1 (en) * 2000-09-01 2007-08-15 Cognis Ip Man Gmbh ORAL AND DENTAL CARE PRODUCTS
JP4820024B2 (en) * 2001-01-10 2011-11-24 昭和薬品化工株式会社 Local anesthetic composition
JP5089840B2 (en) * 2001-09-25 2012-12-05 救急薬品工業株式会社 Nicotine-containing film preparation
CN1309425C (en) * 2001-11-05 2007-04-11 奥拉黑尔斯公司 Treating canker sores with patches to speed healing and relieve pain
EP1601370B1 (en) * 2003-03-12 2015-05-06 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
US20040185009A1 (en) * 2003-03-19 2004-09-23 Dexcel Pharma Technologies Ltd. Composition and device for treating periodontal diseases
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
BRPI0415741B1 (en) 2003-11-07 2013-07-23 tobacco compositions and methods of manufacturing a tobacco composition
WO2005048965A2 (en) * 2003-11-13 2005-06-02 Wm. Wrigley Jr. Company Method and composition for breath freshening
CA2563185C (en) 2004-04-23 2010-04-20 Amgen Inc. Sustained release formulations of a peptide or protein and a purified gallic acid ester
CA2649149A1 (en) * 2006-04-11 2007-10-25 Koko Kosmetikvertrieb Gmbh & Co. Kg Nanoparticle containing nicotine and/or cotinine, dispersions, and use thereof
US8642088B2 (en) 2009-09-04 2014-02-04 Wisconsin Alumni Research Foundation Tannin-chitosan composites
KR101307367B1 (en) * 2010-09-14 2013-09-25 주식회사 이노테라피 Adhesive composition comprising tannin, polyethylene glycol, and water, low carbon alcohol or the mixture thereof
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
FR2972327B1 (en) * 2011-03-11 2017-08-11 Laboratoires Le Stum MUCOADHESIVE NUTRACEUTICAL COMPOSITION COMPRISING ANTIOXIDANT ASSOCIATION
GB2496654A (en) * 2011-11-18 2013-05-22 Reckitt & Colman Overseas Self-assembling peptides
US20130158132A1 (en) * 2011-12-19 2013-06-20 Aida Salatinjants Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
WO2015167257A1 (en) * 2014-04-29 2015-11-05 포항공과대학교 산학협력단 Composition for oral application and method for preparing same
RU2606589C2 (en) * 2015-02-16 2017-01-10 Александр Александрович Кролевец Method of producing tannin nanocapsules
US10532046B2 (en) * 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
WO2021033180A1 (en) * 2019-08-16 2021-02-25 Adel Penhasi Adhesive drug delivery microparticles and a product comprising thereof
US12234578B2 (en) 2020-01-29 2025-02-25 Wisconsin Alumni Research Foundation Tannin composite fibers
US12303564B2 (en) 2021-03-19 2025-05-20 Wisconsin Alumni Research Foundation Composite chitosan-tannin-active agent compositions and methods of making and using same
CN115477920A (en) * 2021-06-15 2022-12-16 西南大学 Preparation method of tannin-based underwater adhesive and product
CN117322671A (en) * 2023-11-01 2024-01-02 东莞市吉纯生物技术有限公司 Nicotine liposome and preparation method thereof and electronic atomized liquid
CN119488503B (en) * 2024-11-14 2025-06-27 沈阳盛京生物细胞研发中心有限公司 Nanometer exosome capsule and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB104609A (en) * 1916-06-05 1917-03-15 Monneron & Guye A Method of Manufacturing a Medicinal Aluminium Preparation.
GB918754A (en) * 1959-08-14 1963-02-20 Armour & Co Improvements in or relating to corticotrophin preparations
GB2036750B (en) * 1978-11-23 1983-05-05 Payne M Tannin complexes
JPS5846011A (en) * 1981-09-14 1983-03-17 Kao Corp hair treatment agent
JPH01166763A (en) * 1987-12-22 1989-06-30 Nitta Gelatin Inc Medical and dental curable material
WO1989010745A1 (en) * 1988-05-02 1989-11-16 Pomerantz, Edwin Compositions and in situ methods for forming films on body tissue
JPH04114655A (en) * 1990-09-03 1992-04-15 Shinonaga Kasei Kk Hard composition for medical use
JPH04312522A (en) * 1991-04-08 1992-11-04 Yoshiaki Kawashima Production of sustained release tablet
JP3496727B2 (en) * 1993-12-27 2004-02-16 救急薬品工業株式会社 Pharmaceutical base
JPH08319232A (en) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd Particulate composition
JP2885668B2 (en) * 1995-09-29 1999-04-26 沢井製薬株式会社 Teprenone formulation

Also Published As

Publication number Publication date
KR20010021911A (en) 2001-03-15
IL134151A0 (en) 2001-04-30
JP2001510788A (en) 2001-08-07
BR9811478A (en) 2000-08-15
AU8578498A (en) 1999-02-16
NO20000284L (en) 2000-03-22
CA2296654A1 (en) 1999-02-04
EP1003483A1 (en) 2000-05-31
HUP0002490A2 (en) 2000-12-28
WO1999004764A1 (en) 1999-02-04

Similar Documents

Publication Publication Date Title
NO20000284D0 (en) Tannic acid polymer compositions for controlled release of pharmaceutical agents, especially in the oral cavity
ATE252562T1 (en) PYRAZOLECARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
DE69902535D1 (en) PHENOXYPROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE60100186D1 (en) ORAL PHARMACEUTICAL FORMULATIONS OF BENZIMIDAZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
FR2811552B1 (en) COMPOSITION, IN PARTICULAR COSMETIC OR PHARMACEUTICAL, IN SOLID FORM
ATE279392T1 (en) INDOLE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL APPLICATION
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
DK1043977T3 (en) Oral pharmaceutical dosage form based on pulsed release
HUP0202100A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
DZ3191A1 (en) Indazole compounds and pharmaceutical compositions inhibiting protein kinases, and methods of using the same.
HUP0102766A3 (en) Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them
IL138969A0 (en) Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0001269A3 (en) 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof
IL145012A0 (en) Fluorine substituted triarylmethane derivatives and pharmaceutical compositions containing the same
DE69933307D1 (en) FLOWABLE, AQUEOUS BORROWING COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
DE69934781D1 (en) MORPHINSULFATE-CONTAINING MICROGRANULATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
FR2802423B1 (en) PHARMACEUTICAL COMPOSITIONS
DE60010113D1 (en) N-GUANIDINALKYLAMID, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING IT
DE60033519D1 (en) MORPHINSULFATE-CONTAINING MICROGRANULATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
ATE222586T1 (en) BENZENESULFONAMIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
DE60010126D1 (en) BRANCHED SUBSTITUTED AMINO DERIVATIVES OF 3-AMINO-1-PHENYL-1H [1,2,4] TRIAZOL, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE244246T1 (en) PYRIDOTHIENODIAZEPINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
NO975680L (en) Oral pharmaceutical preparation of piperidinoalkanol compounds in solution form
DE60200023D1 (en) Isoindoloindolone derivatives, process for their preparation and the pharmaceutical compositions containing them
ATE289595T1 (en) NEW PYRIMIDINE-2,4,6-TRION DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING SAME

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application